Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study.
about
Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation.The role of selected adipokines and ghrelin in the prognosis after myocardial infarction in a 12-month follow-up in the presence of metabolic syndrome.Pleiotropic genes for metabolic syndrome and inflammationMetabolic syndrome and inflammatory biomarkers in adults: a population-based survey in Western region of iran.Osteoprotegerin in Cardiometabolic Disorders.Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome.Dyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes.Sperm parameters: paradigmatic index of good health and longevity.Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.Hyperglycaemia, oxidative stress and inflammatory markers.Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome.Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.Circulating selenoprotein P levels in relation to MRI-derived body fat volumes, liver fat content, and metabolic disorders.The association between impaired glucose tolerance and soluble CD40 ligand: a 15-year prospective cohort study.Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population.Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring.Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome.
P2860
Q33812357-C7752555-F792-48CE-B995-3BDDC07A9C26Q33904442-259E1C6E-C764-49EA-8FDE-C0753CAF2021Q34005816-91A80D47-71A6-4404-A7FA-065611F2FA3FQ34997805-49CBE6EE-4E3E-4A26-8EF0-0AC1F9970490Q35640787-15E20F97-8D62-455A-9291-CB649A7EEF68Q37664564-934DC770-F3AA-47E6-9E66-B1E7DCC2D696Q37681581-CB0C3413-7631-44A8-B54F-A2CF184BE103Q38139822-1F18A132-710F-4982-9F83-0A17148C5D43Q38846653-A5D05B85-BDDF-487A-B198-D86F900D003BQ38918375-C1EEBF7C-C9D0-4490-938D-B67843BDC6B7Q39062582-D944ED52-4E4C-483A-B45D-2EE17685C10DQ39216431-3B9B86FD-3240-486C-90AF-176660216C26Q40214179-10740F94-9F6E-4F13-A8DA-A8CAEED5EE6BQ40988795-7A5E7C50-AC9F-48F8-8BAC-93B7ACE5513EQ41611349-E57D1877-A61A-4929-8A49-474513097F2EQ45858326-DB941843-1007-4DBF-8D7D-AC5738343005Q47686708-F85AD3B5-ED60-4728-AF4B-9AADA9A0EDBCQ52881600-3CD9DE66-1C74-474B-B5EA-2A437DBC189F
P2860
Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@ast
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@en
type
label
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@ast
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@en
prefLabel
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@ast
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@en
P2093
P2860
P50
P356
P1476
Metabolic syndrome and inflamm ...... at the Framingham Heart Study.
@en
P2093
Caroline S Fox
Dhayana Dallmeier
Joao D Fontes
John F Keaney
P2860
P2888
P356
10.1186/1758-5996-4-28
P577
2012-06-20T00:00:00Z
P5875
P6179
1021230543